Ensuring a Smooth Transition: Tech Transfer Strategies for Monoclonal Antibody Drug Products in Late-phase Clinical and Commercial Launch
The successful transfer of a monoclonal antibody (mAb) drug product from late-stage clinical development to commercial-scale manufacturing is a pivotal milestone in ...